Digitization of Integrated Evidence Planning

Join us for an insightful session as we explore the power of digitizing Integrated Evidence Planning (IEP) and its impact on crucial aspects of the pharmaceutical landscape.

Imagine a future where Medical Affairs, Clinical Development, HEOR & RWE, Commercial, Pricing, Market Access, and Patient Engagement seamlessly come together under a unified evidence generation program.

Our discussion will showcase how this integrated approach to digitization serves the needs of key players such as Global Medical Disease Team Asset Leads, Clinical Asset Leads, Worldwide Medical Disease Teams, Market Access/HEOR Professionals, Scientific Communication Experts, and Marketing/Market Research Teams. Additionally, this will demonstrate how the harmonization of processes with technology investments can optimize patient experiences and outcomes across functions.